Drug intelligence / Profile preview

Qixue Shuangbu Wan

Development stage: Unknown
Lead developer: Modern Chinese Medicine Group
Administration: Oral

Overview

Qixue Shuangbu Wan is a traditional Chinese medicine (TCM) herbal formulation developed and marketed by Modern Chinese Medicine Group. It is formulated as an oral pill and is indicated for the treatment of qi and blood deficiency, a TCM diagnostic category that often manifests as anemia, chronic fatigue, and cardiovascular symptoms. As a traditional herbal product, it consists of a synergistic combination of botanical ingredients intended to tonify both the 'qi' (vital energy) and blood. It is currently approved and marketed in China for these indications.

Brand names: Qixue Shuangbu Wan
Other names: Circulation Enhancement Pill气血双补丸

Beyond the preview

Go deeper on Qixue Shuangbu Wan.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Qixue Shuangbu Wan.

Explore the full profile